Clinical Trials Browser

Phase 2/3 × Osteosarcoma × 90 days × Clear all

NCT05691478 2026-05-27

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

Phase 2/3 Recruiting

Osteosarcoma